fda drug shortages semaglutide injection resolved date 2025 π’ has determined the shortage of products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the Hims: Is Tomorrow the End
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 700.Barrera J.G., Jones K.R., Herman J.P., D'Alessio D.A., Woods S.C., Seeley R.J
LDL cholesterol shows modest improvement while HDL (the protective cholesterol) tends to rise
This primarily appears to be due to clinical results since GLP-1s lower A1C, reduce weight, improve cardiovascular outcomes, and potentially many other benefits
Begin conservatively and adjust only under appropriate guidance
